oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study (oneKNEE)
oneKNEE - Prospective, Non-interventional, Multicenter Post-Market Clinical Follow-Up Study
研究概览
详细说明
Safety and Clinical Performance will be observed:
Safety: All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
Clinical Performance: Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Heike Oberascher
- 电话号码:+49 7461 95
- 邮箱:studies@aesculap.de
研究联系人备份
- 姓名:Stefan Maenz, Dr.
- 电话号码:+49 7461 95
- 邮箱:studies@aesculap.de
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Patient age ≤ 80 years
- Indication for a total knee replacement with one of the variants
- Written informed consent
- Willingness and mental ability to participate at the long-term follow-up examinations
Exclusion Criteria:
- Contraindications acc. to the Instructions for Use (IFU)
- Patient age < 18 years
- Known pregnancy
- BMI > 40
- Secondary gonarthrosis (e.g. rheumatoid arthritis, post-traumatic)
- Patients classified as high risk (ASA class >3)
- Patients with immunodeficiency, i.e. patients currently receiving immunosuppressive therapy or patients with severe immunodeficiency requiring drug therapy
- Preoperative: aHKA > 190° or aHKA < 170°
- Preoperative: aHKA > 190° or aHKA < 170°[KB1.1][HO1.2][KB1.3][HO1.4]
- Patients held in a custodial setting und - Patients in a relationship of dependence on the sponsor, the clinic or the investigator
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Safety of the implant
大体时间:2 years after implantation
|
Safety in terms of clinical outcome of oneKNEE® All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
|
2 years after implantation
|
|
Clinical Performance in terms of clinical outcome of oneKNEE®
大体时间:2 years after implantation
|
Clinical Performance in terms of clinical outcome of oneKNEE®. Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state. The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome. |
2 years after implantation
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Intraoperative complications
大体时间:day of surgery
|
day of surgery
|
|
|
Optional: OrthoPilot® Data
大体时间:Day of surgery
|
During surgery all data measured and stored by OrthoPilot® the computer assistant (e.g.
time needed for the surgery, alignment of all implant components) will be evaluated.
|
Day of surgery
|
|
Clinical Outcome by evaluating the Oxford Knee Score
大体时间:V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
|
The Oxford Knee Score, OKS is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA.
It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA.
It is short, reproducible, valid and sensitive to clinically important changes over time.
OKS ranges from 0 to 48 with 48 being the best outcome.
|
V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
|
|
Evaluation of Changes in Quality of Life
大体时间:V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
The EQ-5D-5L is a standardized instrument used to measure health outcomes. Developed by the EuroQol Group (EQ), it assesses five dimensions (5D) of health: Mobility Self-care Usual activities Pain/discomfort Anxiety/depression Each dimension has five levels (5L) of severity: no problems, slight problems, moderate problems, severe problems, and extreme problems |
V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
|
Evaluation of Patient Satisfaction by using PROMS: FJS
大体时间:V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
Forgotten Joint Score (FJS) : A joint-specific questionnaire with the aim to measure PRO of joint disorders . FJS is designed to measure the ability of the patient to "forget" about their problematic joint after treatment. Scale:
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee functional outcome
大体时间:V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
Range of Motion (ROM)
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of LDFA: Lateral distal femoral angle
大体时间:V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
LDFA: Lateral distal femoral angle.
The angle between the mechanical axis of the femur and the knee joint line.
Normal values typically range between 85° and 90° Medial proximal tibial angle (MPTA) and lateral distal femoral angle.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of MPTA: Medial proximal tibial angle
大体时间:V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
MPTA: Medial proximal tibial angle.
The angle between the mechanical axis of the tibia and the knee joint line.
Normal values also typically average around 87° ± 3°.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of HKA: Hip Knee Angle
大体时间:V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
HKA: (Hip Knee Angle).
The mechanical angle between the center of the femoral head, the center of the knee, and the center of the ankle.
It represents the overall lower limb alignment (e.g., neutral, varus, or valgus)
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Radiologically relevant findings by using AI
大体时间:V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
"Image biopsy lab" is a Digital AI platform that supports physicians and healthcare professionals in transforming medical imaging data into diagnostic findings.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Adverse events
大体时间:until end of study, up to 5 years.
|
Serious and non-serious adverse events (SAE/AE)
|
until end of study, up to 5 years.
|
|
Device deficiencies assessed by Adverse Events
大体时间:until end of study, up to 5 years
|
In any case of Adverse Events marked as "related to the product/device"
|
until end of study, up to 5 years
|
|
Survival of implant components
大体时间:From V3=Discharge to V7= 5 years post OP
|
From V3=Discharge to V7= 5 years post OP
|
|
|
Anterior knee pain
大体时间:V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively. (Feller et al., J Bone Joint Surg Am. 2003 Feb;85(2):212-7). |
V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
合作者和调查者
赞助
调查人员
- 首席研究员:Anne Postler, PD Dr. med、Städt. Klinikum Dresden
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- AAG-O-H-25103
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.